Amy Huber
Johannesburg, Gauteng, 2193, South Africa
NCT Number: NCT04170374
In its 2017 revision of the global guidelines for HIV care and treatment, the World Health Organization called for rapid or same-day initiation of antiretroviral treatment (ART) for eligible patients testing positive for HIV. The South African National Department of Health adopted this recommendation in October 2017. Neither organization provided detailed guidance, however, on how to implement the recommendation.
In sub-Saharan Africa, where most HIV patients are located, studies continue to document high losses of treatment-eligible patients from care before they receive their first dose of antiretroviral medications (ARVs). Among facility-level reasons for these losses are treatment initiation protocols that require multiple clinic visits and long waiting times before a patient who tests positive for HIV is dispensed an initial supply of medications. There is very little published evidence on the practical details of the process and the extent to which it varies by facility, setting, or country. Without a robust baseline evidence base, it is challenging to identify opportunities for making improvements. The SPRINT (Survey of Procedures and Resources for Initiating Treatment of HIV in Africa) study will begin to develop this evidence base. SPRINT will combine a facility-level description of the standard of care with a retrospective record review of patients who recently initiated ART at the study sites. Data will be collected from 12 clinics across 3 provinces in South Africa (KwaZuluNatal Province, Gauteng Province, and Limpopo Province). The survey will elicit detailed information about current procedures through structured interviews with clinic staff. The record review for a retrospective cohort of patients eligible for ART will estimate actual numbers of clinic visits, services provided, and duration of the steps for treatment initiation from start to finish. SPRINT is expected to identify differences in approaches to treatment initiation and potential opportunities for improvement.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Johannesburg, Gauteng, 2193, South Africa
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study will collect routine medical record data from the electronic medical record system, other electronic databases, and paper charts.
Clinicians and lay staff will be interviewed regarding the ART initiation process.
Time frame: Up to 6 months after treatment eligibility determined
Number of health system interactions required between HIV diagnosis and first dispensing of ARVs
Time frame: Up to 6 months after treatment eligibility determined
Average number of days required between HIV diagnosis and first dispensing
Boston University
Other
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa: The SPRINT Study in South Africa
Acronym: SPRINT-SA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06647797
Antenatal Care, Antiretroviral Therapy
Gombe, Uganda
View Trial DetailsNCT04470011
Antiretroviral Therapy, HIV
Johannesburg, Gauteng, South Africa
View Trial DetailsNCT04468399
Antiretroviral Therapy, HIV
Lilongwe, Malawi
View Trial DetailsNCT02086630
Antiretroviral Therapy, HIV
New York, United States
View Trial Details